Literature DB >> 9298889

Active fulminant myocarditis characterized by T-lymphocytes expressing the gamma-delta T-cell receptor: a new disease entity?

M Eck1, A Greiner, R Kandolf, B Schmausser, A Marx, H K Müller-Hermelink.   

Abstract

Lymphocytic myocarditis is thought to be a virus-induced disease. T cells expressing the alpha-beta T-cell receptor seem to play a central role in the pathogenesis and to mediate tissue injury in this disease. A case of active fulminant myocarditis is described, which was analyzed by immunohistochemical, molecular biologic, and serologic methods. Infiltration of the heart tissue predominantly by gamma-delta T cells was detected by immunohistochemistry. No evidence of viral disease could be obtained by in situ hybridization with different enterovirus-specific DNA probes; by reverse-transcriptase polymerase chain reaction using specific primers for enteroviruses, adenoviruses, herpes simplex viruses, influenza A and B viruses, and cytomegaloviruses; or by enzyme-linked immunosorbent assay and electron microscopy. Because gamma-delta T cells may have an autoimmune capacity, we propose that these cells may trigger autoimmune myocarditis. These findings may be important in order to identify subgroups of patients who may benefit from immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298889     DOI: 10.1097/00000478-199709000-00017

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  2 in total

1.  Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function.

Authors:  Marina Afanasyeva; Dimitrios Georgakopoulos; Diego F Belardi; Amrish C Ramsundar; Jobert G Barin; David A Kass; Noel R Rose
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

Review 2.  Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.

Authors:  Wei Liu; Sally A Huber
Journal:  Virol J       Date:  2011-01-21       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.